Scleredema in a Patient with AIDS-Related Lipodystrophy Syndrome

Scleredema in a Patient with AIDS-Related Lipodystrophy Syndrome

Scleredema is a form of cutaneous mucinosis caused by an increased accumulation of collagen and mucin in the dermis. It is characterized by diffused, nonpitting swelling and induration of the skin. Scleredema diabeticorum is one type of scleredema associated with diabetes mellitus. AIDS-related insu...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ralph Yachoui, Pamela Traisak, Shirish Jagga
Format:	Article
Language:	English
Published:	Wiley 2013-01-01
Series:	Case Reports in Endocrinology
Online Access:	http://dx.doi.org/10.1155/2013/943798
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Scleredema Diabeticorum in a Patient with Type 2 Diabetes Mellitus
by: C. Martín, et al.
Published: (2011-01-01)

Bioplastia na lipodistrofia de pacientes com HIV/AIDS Bioplasty for lipodystrophy in patients with HIV/AIDS
by: Marilho Tadeu Dornelas, et al.
Published: (2012-09-01)

Lipodystrophy induced by combination antiretroviral therapy in HIV/AIDS patients: A Belgrade cohort study
by: Dragović Gordana, et al.
Published: (2014-01-01)

Congenital generalized lipodystrophy: Berardinelli syndrome. Report of two siblings
by: F Gürakan, et al.
Published: (1995-07-01)

Partial lipodystrophy with renal disorder
by: Y Saraçlar, et al.
Published: (1972-01-01)

Cutis Verticis Gyrata in Men Affected by HIV-Related Lipodystrophy
by: Keshav Khanijow, et al.
Published: (2013-01-01)

Combination of familial partial lipodystrophy (Dunnigan-Cobberling syndrome) with pulmonary sarcoidosis
by: N. V. Frolkova, et al.
Published: (2024-07-01)

Acquired lipodystrophy following use of pembrolizumab
by: Maya Weitzen, et al.
Published: (2024-12-01)

Giant fibrolipoma mimicking abdominal lipodystrophy
by: Kenan Yusuf Coban, et al.
Published: (2008-01-01)

The impact of dermolipectomy in improving the quality of life in patients with abdominal lipodystrophy
by: Marilia de Pádua Dornelas Correa, et al.
Published: (2016-06-01)

Causes of death in patients with Berardinelli-Seip congenital generalized lipodystrophy.
by: Josivan Gomes Lima, et al.
Published: (2018-01-01)

The Effects of Thiazolidinediones on Metabolic Complications and Lipodystrophy in HIV-Infected Patients
by: Jussi Sutinen
Published: (2009-01-01)

Mycoplasma Pneumoniae with Atypical Stevens-Johnson Syndrome: A Diagnostic Challenge
by: Ralph Yachoui, et al.
Published: (2013-01-01)

Antiretroviral-Related Adipocyte Dysfunction and Lipodystrophy in HIV-Infected Patients: Alteration of the PPARγ-Dependent Pathways
by: Martine Caron, et al.
Published: (2009-01-01)

Preclinical evaluation of candidate “kill or cure” strategies to treat MFN2-related lipodystrophy
by: Ineke Luijten, et al.
Published: (2025-08-01)

The clinical approach to child and adolescent patients with lipodystrophy: a series of international case discussions
by: Rebecca J. Brown, et al.
Published: (2025-08-01)

Large-volume liposuction in acquired partial lipodystrophy: a case report
by: Yasiru Gehan Karunaratne, et al.
Published: (2019-09-01)

HIV facial lipodystrophy treatment by polylactic acid – a literature review
by: Adam Solarz, et al.
Published: (2024-11-01)

Lipodystrophy of Abdominal Pannus: A Severe Complication of Phosphatidyl Choline Injections
by: Parag S. Telang
Published: (2021-04-01)

P348: Short stature and partial lipodystrophy along with hypersomnolence and PCOS: Rarity and phenotypic expansion of SHORT syndrome
by: Marisa-Nicole Zayat, et al.
Published: (2025-01-01)

Hyperandrogenism as a clinical manifestation of familial partial lipodystrophy type 2 in an adolescent female patient
by: Ewa Błaszczyk, et al.
Published: (2025-03-01)

Systemic Lupus Erythematosus Associated with Erythema Multiforme-Like Lesions
by: Ralph Yachoui, et al.
Published: (2013-01-01)

Lipodystrophy at the insulin injection sites: current trends in epidemiology, diagnostics and prevention
by: Vadim V. Klimontov, et al.
Published: (2020-06-01)

HIV-associated lipodystrophy: epidemiological analysis of a Plastic Surgery Service in Brazil
by: Murilo Sgarbi Secanho, et al.
Published: (2023-05-01)

A real-world pharmacovigilance assessment and literature review of lymphoma development in lipodystrophy
by: Rebecca J. Brown, et al.
Published: (2025-05-01)

A case of familial partial lipodystrophy type 2 masquerading as Cushing syndrome: Explaining an atypical phenotype by whole-exome sequencing
by: Enid Perez-Dionisio, et al.
Published: (2025-03-01)

Prevalence of clinical characteristics of lipodystrophy in the US adult population in a healthcare claims database
by: Seonkyeong Yang, et al.
Published: (2024-07-01)

Treatment of facial lipodystrophy induced by a biologic agent (IPD-1): a literature review
by: Henri Friedhofer, et al.
Published: (2024-11-01)

Brazilian expert consensus on the diagnosis, classification, screening for complications and treatment of familial partial lipodystrophy
by: Cynthia Melissa Valerio, et al.
Published: (2025-06-01)

Effects of switching from stavudine to raltegravir on subcutaneous adipose tissue in HIV-infected patients with HIV/HAART-associated lipodystrophy syndrome (HALS). A clinical and molecular study.
by: Pere Domingo, et al.
Published: (2014-01-01)

WCN25-4107 An interesting case report of minimal change disease presenting as nephrotic syndrome in young female with partial lipodystrophy, Dunnigan type
by: Arshdeep Singh, et al.
Published: (2025-02-01)

Neuroanatomical characterisation of the expression of the lipodystrophy and motor-neuropathy gene Bscl2 in adult mouse brain.
by: Alastair S Garfield, et al.
Published: (2012-01-01)

A very low carbohydrate diet improved metabolic profile in congenital generalized lipodystrophy type 4
by: Sayantan Chakraborty, et al.
Published: (2025-01-01)

Systematic review of antiretroviral-associated lipodystrophy: lipoatrophy, but not central fat gain, is an antiretroviral adverse drug reaction.
by: Reneé de Waal, et al.
Published: (2013-01-01)

Subjectivités et constructions sociales d’un risque iatrogène : (in)visibilités des lipodystrophies au Sénégal
by: Alice Desclaux, et al.
Published: (2019-06-01)

Liraglutide use in pediatric type 2 familial partial lipodystrophy caused by LMNA mutation: a case report
by: Youran Li, et al.
Published: (2025-07-01)

Case Report: Concurrent de novo pathogenic variants in the LMNA gene as a cause of sporadic partial lipodystrophy
by: José L. Santos, et al.
Published: (2024-11-01)

Development of metabolic syndrome at a young age as a manifestation of familial partial lipodystrophy type 3 (PPARG mutation): the first description of its clinical case in Russia
by: Ekaterina Leonidovna Sorkina, et al.
Published: (2015-10-01)

Hemophagocytic Syndrome Associated with Immune Reconstitution Inflammatory Syndrome in a Patient with AIDS Related Burkitt’s Leukemia/Lymphoma
by: Metin Kanıtez, et al.
Published: (2014-01-01)

Corrigendum: Familial partial lipodystrophy resulting from loss-of-function PPARγ pathogenic variants: phenotypic, clinical, and genetic features
by: Reivla Marques Vasconcelos Soares, et al.
Published: (2024-12-01)